Xue, Ruicong
Liu, Chen
Yu, Qian
Dong, Yugang
Zhao, Jingjing
Article History
Accepted: 10 March 2025
First Online: 19 April 2025
Declarations
:
: This work was supported by funding from the Clinical Research Foundation of the Cardiovascular Society of the Chinese Medical Association and the 2022–2024 Guangdong Basic and Applied Basic Research Foundation to the authors’ institutions, Guangdong National Science Foundation (Nos. 2022A1515012161, 2022A1515010227, 2023A1515011794, 2024A1515010458) and by Merck Serono Co., Ltd, Beijing, China.
: Q.Y. is an employee of Merck Serono Co., Ltd, China (an affiliate of Merck KGaA Darmstadt, Germany). All other authors report no conflict of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: No new data were generated or analyzed in support of this research.
: Not applicable.
: All authors were involved with the conception and design of this manuscript, the drafting and critical revision of the manuscript, and final approval of the manuscript.